Axxcess Wealth Management
VRTX icon

Axxcess Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Axxcess Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$481K Sell
920
-154
-14% -$78.9K 0.02% 579
2026
Q2 		$533K Buy
+1,074
New +$476K 0.01% 699
2026
Q1 		– Sell
-565
Closed -$256K – 989
2025
Q4 		$256K Buy
+565
New +$244K ﹤0.01% 900
2025
Q1 		– Sell
-1,052
Closed -$424K – 942
2024
Q4 		$424K Sell
1,052
-1,798
-63% -$833K 0.01% 584
2024
Q3 		$1.33M Buy
2,850
+405
+17% +$195K 0.03% 335
2024
Q2 		$1.15M Buy
2,445
+217
+10% +$94.2K 0.03% 345
2024
Q1 		$931K Buy
2,228
+560
+34% +$237K 0.03% 387
2023
Q4 		$679K Sell
1,668
-329
-16% -$122K 0.02% 443
2023
Q3 		$694K Buy
1,997
+685
+52% +$240K 0.02% 386
2023
Q2 		$462K Buy
1,312
+60
+5% +$20.2K 0.03% 369
2023
Q1 		$394K Sell
1,252
-691
-36% -$207K 0.03% 422
2022
Q4 		$561K Sell
1,943
-903
-32% -$275K 0.05% 339
2022
Q3 		$824K Sell
2,846
-262
-8% -$75.4K 0.08% 219
2022
Q2 		$876K Buy
3,108
+22
+0.7% +$5.89K 0.08% 209
2022
Q1 		$805K Buy
3,086
+378
+14% +$89.7K 0.06% 261
2021
Q4 		$595K Buy
+2,708
New +$527K 0.04% 318

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Axxcess Wealth Management's VRTX Position: Q3 2026 in Review

Axxcess Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q3 2026, selling an estimated $78.9K and leaving 920 shares worth $481K. The position accounts for 0.02% of the portfolio, ranked #579.

Axxcess Wealth Management first reported a position in VRTX in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.33M in Q3 2024. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Axxcess Wealth Management held 920 shares of Vertex Pharmaceuticals worth $481K as of Q3 2026.
  • Axxcess Wealth Management sold 154 Vertex Pharmaceuticals shares in Q3 2026, an estimated $78.9K.
  • Vertex Pharmaceuticals made up 0.02% of Axxcess Wealth Management's portfolio in Q3 2026, its #579 holding.
  • Axxcess Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Axxcess Wealth Management's Vertex Pharmaceuticals position peaked at $1.33M in Q3 2024.
  • 1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Axxcess Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.